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Abstract 
Objective: The burden of diabetes mellitus has exponentially increased in low resource settings. Patients with dia-
betes are more likely to exhibit poor mental health which negatively affects treatment outcomes. However, patients 
with high levels of social support (SS) are likely to report optimal mental health. We sought to determine how SS 
affects the report of psychiatric morbidity and health-related quality of life (HRQoL) in 108 diabetic patients in Harare, 
Zimbabwe.
Results: The average age of participants was 54.1 (SD 18.6) years. Most of the participants were; females (69.4%), mar-
ried (51.9%), and were of low level of income (43.5%). 37.1% of the participants exhibited signs of psychiatric morbid-
ity [mean Shona Symptoms Questionnaire score—6.7 (SD 3.2)]. Further, patients also reported lower HRQoL [mean 
EQ-5D-VAS score—64.1 (SD 15.3)] and high levels of SS [mean Multidimensional Scale of Perceived Social Support 
score—43.7 (SD 11.5)]. Patients who received greater amount of SS had optimal mental health. Being female, unmar-
ried, lower education attainment, having more comorbid conditions, being diagnosed with type 2 diabetes and 
having been diagnosed of diabetes for a longer duration were associated with poorer mental health. It is important to 
develop context-specific interventions to improve diabetic patients’ mental health.
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Introduction
The global burden of non-communicable diseases 
(NCDs) including diabetes has exponentially increased 
over the past few decades [1–7]. Accordingly, the world-
wide prevalence of diabetes mellitus (DM) is projected to 
double by the year 2030 [1–3, 8]. Increasing globalisation, 
trends towards unhealthy diets, obesity, increased social 
inequality, and sedentary lifestyles have further exacer-
bated the worldwide burden of chronic NCDs [2, 4–10]. 
Unfortunately, the burden of diabetes is disproportion-
ately substantial in low resource settings with 85% of 
all people with undiagnosed diabetes residing in low to 
middle-income countries [5–9]. For example, the burden 
of DM has significantly increased in Zimbabwe in the last 
30  years, and its prevalence is currently conservatively 
pegged at 10% [11]. As in other low resource settings, a 
lack of resources and failure by governments to prioritise 
the screening and treatment of diabetes further perpetu-
ates the pandemic [1–7, 12]. This is rather unfortunate as 
several systematic reviews and meta-analysis have shown 
that patients with diabetes are more likely to exhibit poor 
mental health [10–15]. For instance, the prevalence of 
depression is thrice in patients with diabetes as compared 
to the normative population [10, 13–15]. The burden of 
a chronic and life-long disorder predisposes patients to 
poor mental health functioning [16].
If unabated, negative mental health indices such as 
depression, anxiety and stress result in; poorer glycaemic 
control, decreased health-related quality of life (HRQoL), 
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poorer adherence with DM treatment regime, treatment 
failure, increased odds of developing diabetes-related 
complications, increased health care utilisation and asso-
ciated costs, and increased mortality [10, 15–20]. On the 
contrary, research suggests that an adequate amount of 
social support (SS) optimises treatment outcomes and 
patients’ mental health [10, 21]. For example, Tang et al. 
[22] carried out a cross-sectional survey of African-
American diabetic patients (N = 89) to assess the rela-
tionship between SS and HRQoL. The study showed that 
SS; enhances self-management behaviours (healthy diet 
intake, frequent glucose level monitoring, consistent 
medication intake and regular physical activity engage-
ment), and results in increased patient HRQoL. Social 
support can occur in various ways including; emotional, 
informational, financial, and affirmational support [22]. 
Although diabetes mellitus is one of the most prevalent 
NCDs [11], there is a lack of information on the mental 
health profile of patients from low-resource settings. This 
study, therefore, sought to assess the effects of social sup-




The study was carried at outpatient diabetic clinics at 
Parirenyatwa Group of Hospitals (PGH), Harare Central 
Hospital (HCH) and the Zimbabwe Diabetes Association 
(ZDA). PGH and HCH are the largest referral hospitals 
in Zimbabwe. The ZDA is a private facility which offers 
routine diabetic services including check-ups, medica-
tions supplies, health education and promotion talks, and 
community awareness and advocacy activities.
Participants
Based on the study by Tang et  al. [22] which yielded 
mean SS scores of 3.5 (SD = 1.3), we expected SS levels 
of Zimbabwean patients to be lower due to differences in 
socio-economic context, therefore assuming the follow-
ing parameters;  U0 = 3.5,  U1 = 3.2, α = 0.05, β = 0.80, the 
minimum sample size was 150 participants. We conse-
quently recruited adults diabetic patients (≥ 18  years) 
who were available during the study period and had given 
written consent. Diabetic patients with hearing impair-
ments were excluded as we had no financial resources to 
hire interpreters. We also excluded patients who did not 
understand either English or Shona as study tools had 
been previously validated in Shona (a Zimbabwean native 
language) and English languages.
Instruments
Participants’ characteristics, psychiatric morbid-
ity, social support and HRQoL were measured using a 
purpose-built questionnaire, the Shona Symptom Ques-
tionnaire (SSQ), the Multidimensional Scale of Perceived 
Social Support (MSPSS), and the EQ-5D respectively. 
The demographic questionnaire extracted information 
on potential covariates, i.e. participants’ age, sex, educa-
tional level, marital status, financial status, type of diabe-
tes, duration of diagnosis and comorbidities. Developed 
in Zimbabwe, the SSQ consists of local idioms and inter-
nationally recognised items expressive of common men-
tal disorders (CMDs). The 14-item screen is especially 
sensitive in screening for depression and anxiety disor-
ders [23]. The SSQ scoring is based on a binary response 
system, i.e. a yes response scores one point while a no 
response is equivalent to zero. A score of eight or higher 
on the SSQ indicates a high risk of psychiatric morbidity 
[24]. The MSPSS is a 12-item self-report measure of how 
one perceives their social support system, i.e. partici-
pants quantify support received from family, friends, and 
significant others. Items on the MSPSS are rated from 
one (strongly disagree) to five (strongly agree), the higher 
the score, the greater the social support [25]. The EQ-5D 
is a generic HRQoL which rates participants’ five dimen-
sions, i.e. self-care, usual activities, pain/discomfort and 
anxiety/depression. Participants also rate their health on 
a visual analogue scale which ranges from zero (worst 
imaginable health state) to 100 (the best possible health 
state) [26, 27]. All study instruments have been previ-
ously validated in in the Zimbabwean context [24, 28, 29].
Procedure
Approval to carry out the study was granted by; ZDA, 
HCH ethical committee and the Joint Research and Eth-
ics Committee for the University of Zimbabwe, College of 
Health Sciences & Parirenyatwa Group of Hospitals (Ref: 
JREC/361/17). Prospective participants were approached 
as they awaited receiving services at the different clinical 
sites. The primary researcher (AMN) briefly explained 
the study aims and distributed the study pack which con-
tained a detailed information letter, consent form and 
study outcome measures. Participants were required to 
give written consent before self-completing the study 
outcome measures. The researcher was available to 
attend to participants who had any queries and com-
pleted questionnaires were collected on the same day.
Data analysis and management
Data were captured into Microsoft Excel and analysed 
using STATISTICA (version 14). Normality was checked 
using the Shapiro-Wilkin Test and; participants charac-
teristics, EQ-5D, SSQ and MSPSS outcomes were sum-
marised using descriptive statistics such as means and 
frequencies. Correlation co-efficiencies, Chi square/
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Fishers’ exact tests, and t-tests were used to determine 
the factors influencing patients’ mental health outcomes.
Results
As seen in Table 1, the mean age of the participants was 
54.1 (SD 18.6) years. Most participants; were female 
(69.4%), married (51.9%), educated (91.7%), employed 
(48.2%), and reported of below average income (53.7%), 
diagnosed with diabetes type 2 (55.6%), had been diag-
nosed for at least 6 years, and hypertension was the most 
common comorbid condition (46.3%). Significant other 
and friends were cited as the greatest and least sources 
of social support, and the mean social support (MSPSS) 
scores were 43.7 (SD 11.5). Participants’ mean HRQoL 
(EQ-5D utility & VAS) scores were 0.758 (SD 0.2) and 
64.1 (SD 15.3) respectively. 37.1% of the participants 
exhibited signs of psychiatric morbidity, and the mean 
SSQ score was 6.7 (SD 3.2). Patients who received an 
adequate amount of social support reported lower psy-
chiatric morbidity and greater HRQoL (see Table  2). 
Additionally, being female, unmarried, lower education 
attainment, having a greater number of comorbids, being 
diagnosed with type 2 diabetes and having been diag-
nosed of diabetes for a longer duration were associated 
Table 1 Descriptive statistics, N = 108
a Data not presented in the n (%) format
Variable Attribute Frequency n (%)
Gender Female 75 (69.4)
Male 33 (30.6)
Agea Mean (SD) 54.1 (18.6)
Marital status Single 16 (14.8)
Married 56 (51.9)
Widowed 36 (33.3)




Employment status Unemployed 35 (32.4)
Formally employed 34 (31.5)
Self-employed 18 (16.7)
Retired 21 (19.4)




Diabetes type Type 1 48 (44.4)
Type 2 60 (55.6)
Years post  diagnosisa Median  [Q1–Q3] 6 [3–15]





Social support (MSPSS)  scoresa Family [mean (SD)] 4.0 (SD 1.1)
Friends [mean (SD)] 2.8 (SD 1.3)
Significant other [mean (SD)] 4.1 (SD 1.1)
Summative score [mean (SD)] 43.7 (SD 11.5)
HRQoL (EQ-5D)  scoresa Utility [mean (SD)] 0.758 (0.2)
VAS score [mean (SD)] 64.1 (15.3)
Psychiatric morbidity (SSQ)  scoresa SSQ scores ≥ 8 [n (%)] 40 (37.1)
Summative score [mean (SD)] 6.7 (SD 3.2)
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with poorer mental health (see Table  3). Please refer to 
Additional files 1, 2, 3 for frequencies of responses on the 
MSPSS, EQ-5D and SSQ respectively.  
Discussion
The current study revealed that CMDs are prevalent 
in diabetic patients. Further, patients who received an 
adequate amount of social support had the best mental 
health outcomes, i.e. lower psychiatric morbidity and 
greater HRQoL, and this is congruent with previous 
studies [10, 21]. Most participants received their social 
support from their significant others, with the least sup-
port coming from friends. Many of the participants were 
married and therefore presumably received support from 
their spouses, and this may partially explain the discrep-
ancies in sources of social support. However, there were 
subtle differences between support received from the 
family and significant other; which may be attributed to 
the Zimbabwean culture whereby it may be difficult for 
participants to succinctly distinguish between significant 
others and family as the two terms are often used inter-
changeably [29]. Further, patients who had more substan-
tial financial resources reported of greater social support 
as having a stable source of income has been shown to 
be associated with the more considerable social network 
size [30].
When compared to the general population [31], 
patients with diabetes reported of lower HRQoL. The 
lower HRQoL can be attributed to pathological processes 
such as diabetic peripheral neuropathy (DPN). For exam-
ple, DPN results in damage to peripheral nerves, which 
consequently leads to pain, reduced sensation and numb-
ness, and these associated impairments negatively affect 
the patients’ HRQoL [32]. Further, restrictive treatment 
regimens (e.g. daily insulin shots and a strictly controlled 
diet free of refined and sugary foods) and DM-associ-
ated complications such as retinopathy and sexual dys-
function, may further negatively impact the HRQoL of 
DM patients and exacerbate their psychiatric morbidity 
[33–37]. More so, DM patients also reported depres-
sion, other studies have shown that diabetes and depres-
sion share the same pathophysiological/causal pathways 
[20]. Additionally, patients who had been diagnosed with 
DM for a more extended period also exhibited poorer 
HRQoL and greater psychiatric morbidity. The decreased 
mental health may be attributed to the increased burden 
imposed by complications of diabetes as the disease pro-
gresses over time [33, 37]. DM is, unfortunately, a pro-
gressive degenerative disease, i.e. the condition worsens 
with the passage of time regardless of treatment status 
[38]. Further, patients with type one diabetes reported 
of better HRQoL as compared to their type two coun-
terparts. Type one diabetes usually affects the younger 
Table 2 Relationships between mental outcomes, N = 108
MSPSS SSQ EQ-5D EQ-5D
Utility score VAS score
MSPSS 1 Rho = − 0.190, p = 0.049 Rho = 0.240, p = 0.012 Rho = 0.242, p = 0.012
SSQ Rho = − 0.190, p = 0.049 1 Rho = − 0.310, p < 0.001 Rho = − 0.380, p < 0.001
EQ-5D utility Rho = 0.240, p = 0.012 Rho = − 0.310, p = 0.001 1 Rho = 0.422, p < 0.001
EQ-5D VAS Rho = 0.242, p = 0.012 Rho = − 0.380, p < 0.001 Rho = 0.422, p < 0.001 1
Table 3 Determinants of mental health outcomes, N = 108
* Flagged associations were statistically significant
Variable MSPSS SSQ EQ-5D EQ-5D
Utility score VAS score
Age Rho = − 0.1, p = 0.458 Rho = .09, p = 0.303 *Rho = − 0.4, p < 0.001 *Rho = − 0.3, p < 0.001
Gender t (df = 106) = − 1.28, p = 0.203 *t (df = 106) = 3.9, p < 0.001 t (df = 106) = − 1.4 p = 0.203 *t (df = 106) = − 1.8, p = 0.078
Marital status X2 (df = 3) = 6.2, p = 0.101 *X2 (df = 3) = 10.2, p = 0.0169 *X2 (df = 3) = 28.7, p < 0.001 X2 (df = 3) = 6.1, p = 0.11
Level of education X2 (df = 3) = 3.9, p = 0.273 X2 (df = 3) = 2.6, p = 0.45 *X2 (df = 3) = 16.2, p = 0.001 *X2 (df = 3) = 11.4, p = 0.01
Employment status *X2 (df = 4) = 9.8, p = 0.044 X2 (df = 4) = 1.6, p = 0.807 *X2 (df = 4) = 22.7, p = 0.0001 *X2 (df = 4) = 22.7, p = 0.0001
Level of income X2 (df = 4) = 1.1, p = .888 X2 (df = 4) = 4.8, p = .312 X2 (df = 4) = 8.2, p = 0.0847 *X2 (df = 4) = 9.8, p = 0.0444
Diabetes duration Rho = − 0.112, p = 0.250 Rho = 0.075, p = 0.442 *Rho = − 0.33, p < 0.001 Rho = − 0.293, p = 0.002
Type of diabetes *t (df = 106) = 2.6, p = 0.009 t (df = 106) = 0.684, p = .496 *t (df = 106) = 2.9, p = 0.005 t (df = 106) = 1.4, p = 0.152
Comorbidities Rho = − 0.11, p = 0.256 Rho = 0.210, p = 0.029 *Rho = − 0.447, p < 0.001 Rho = − 0.167, p = 0.083
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population who often have fewer disease-related compli-
cations [39]. Additionally, type one DM patients notably 
received more SS as compared to their type two coun-
terparts. Type one diabetes has an earlier onset when the 
patient is still a minor, consequently, the immediate fam-
ily is likely to be inclined/obliged to taking better care of 
minors and offer them more social support [40].
Studies suggest that a negative correlation exists 
between mental health issues and HRQoL of patients 
with diabetes as the complications and the burden that 
comes with DM exerts more psychological stress on 
individuals with diabetes thus increasing their risk of 
psychiatric morbidity [39, 41, 42]. Consistent with previ-
ous studies, the present study suggests that high levels of 
SS may result in the reduction of psychiatric morbidity 
and improved HRQoL in diabetic patients [10, 21, 22]. 
In the current study, female participants reported higher 
psychiatric morbidity. Previous studies have shown that 
compared to men, women are more likely to admit and 
open when something is wrong as compared to males 
who would prefer portraying themselves as healthy and 
“macho” [43]. This is, however, a priori, and further quali-
tative studies are warranted to understand the mental 
health of Zimbabwean patients with diabetes better. 
Additionally, married participants reported the least psy-
chiatric morbidity scores; this is unsurprising given the 
buffering effect of SS on diabetes burden and diabetes-
associated distress [44].
Conclusion
The present study revealed that Zimbabwean DM 
patients reported poorer mental health and that patients 
who received an optimal amount of SS had the least psy-
chiatric morbidity and greater HRQoL. Further, contex-
tual factors, i.e. being female, unmarried, lower education 
attainment, having a higher number of comorbids, being 
diagnosed with type two (2) diabetes and having been 
diagnosed of diabetes for a longer duration were asso-
ciated with poorer mental health. There is, therefore, 
need to routinely screen and appropriately refer patients 
with poor mental health for treatment. It is also essen-
tial to validate mental health outcomes in DM patients to 
increase mental health surveillance. Importantly, there 
is an enormous need to develop and implement context-
specific interventions to improve the HRQoL of diabetic 
patients residing in low-resource settings.
Limitations
The following methodological limitations are a threat 
to both the internal and external validity of the study 
outcomes:
• Data were collected cross-sectionally, causality can-
not be inferred
• Participants were conveniently selected, there is 
therefore a possibility of selection bias
• Participants were only recruited from urban settings. 
However, 67% of the Zimbabwean population resides 
in rural areas [45]. Thus, outcomes may have limited 
generalisability
• We utilized generic mental health outcomes which 
may have limited content validity in unpacking men-
tal health of DM patients
• Clinical data such as type and duration of diabetes 
was self-reported.
Additional files
Additional file 1. Frequencies of responses on the MSPSS, N=108. Table 
denotes frequencies of responses on the MSPSS, a 12-item social support 
outcome measure. Responses are rated on a five-point Likert scale, rang-
ing from strongly disagree=1 to strongly agree=5.
Additional file 2. Frequencies of responses on the EQ-5D, N=108. Table 
denotes frequencies of responses on the EQ-5D, a generic health-related 
quality of life measure. Respondents indicate whether they had problems 
in with self-care, usual activities, mobility, pain/discomfort and anxiety/
depression on a three-adjunct scale. Responses are rated as “no problem”, 
“some problem” and “extreme problem”.
Additional file 3. Frequencies of responses on the SSQ, N=108. Table 
denotes frequencies of responses on the SSQ, a 14-item, binary common 
mental disorders (CMDs) screen. Respondents indicate if they had experi-
enced any of the enlisted symptoms in the last seven days. A yes response 
is scored as “one” and no as “zero”, a score ≥ 8 is indicative of risk of CMD.
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